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Natural killer group 2 member D (NKG2D) is an activating receptor that is expressed on
most cytotoxic cells of the immune system, including NK cells, γδ, and CD8+ T cells. It
is still a matter of debate whether and how NKG2D mediates priming of CD8+ T cells in
vivo, due to a lack of studies where NKG2D is eliminated exclusively in these cells. Here,
we studied the impact of NKG2D on effector CD8+ T-cell formation. NKG2D deficiency
that is restricted to murine CD8+ T cells did not impair antigen-specific T-cell expansion
following mouse CMV and lymphocytic choriomeningitis virus infection, but reduced
their capacity to produce cytokines. Upon infection, conventional dendritic cells induce
NKG2D ligands, which drive cytokine production on CD8+ T cells via the Dap10 signaling
pathway. T-cell development, homing, and proliferation were not affected by NKG2D
deficiency and cytotoxicity was only impaired when strong T-cell receptor (TCR) stimuli
were used. Transfer of antigen-specific CD8+ T cells demonstrated that NKG2D deficiency
attenuated their capacity to reduce viral loads. The inability of NKG2D-deficient cells to
produce cytokines could be overcomewith injection of IL-15 superagonist during priming.
In summary, our data show that NKG2D has a nonredundant role in priming of CD8+
T cells to produce antiviral cytokines.
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Introduction
CD8+ T-cell activation following viral infection is a tightly con-
trolled process that does not only require stimulation of their
antigen receptor, but also costimulation by membrane-bound lig-
ands and cytokines from antigen-presenting cells (APCs) and
CD4+ helper T cells [1, 2]. Costimulation provides activated CD8+
T cells with essential signals that prevent activation-induced cell
death [1]. In addition, costimulation unlocks the full potential of
CD8+ T cells, promoting proliferation, cytokine production, and
cytotoxicity [1]. A large number costimulatory receptors have been
identified, most notably CD28 and members of the TNF receptor
superfamily [3, 4].
A molecule of particular interest for T-cell activation is the
c-type lectin-like receptor natural killer group 2 member D
(NKG2D), encoded by killer cell lectin like receptor K1 (Klrk1).
NKG2D is an activating receptor that is expressed on cytotoxic
cells such as NK cells, NKT cells, and γδ T cells [5]. NKG2D is not
present on na¨ıve murine CD8+ T cells, but is induced after anti-
gen encounter [6]. Multiple ligands for NKG2D have been identi-
fied, including MICA, MICB, and ULBP1-6 in humans and Rae1α-
ε, H60a-c, and MULT1 in mice [7]. NKG2D ligands are typically
induced in response to stress factors such as infection or oncogenic
transformation [5]. NKG2D ligands are also observed in absence of
overt infection such as on bone marrow (BM) stroma [5]. NKG2D
signals through the adaptor molecules DAP10 and DAP12, which
mediate direct cytotoxic killing of target cells upon recognition of
ligands by NK cells [8]. CD8+ T cells lack expression of DAP12 and
in these cells NKG2D was proposed to function as a costimulatory
receptor [9]. In vitro systems trying to establish the exact costim-
ulatory role of NKG2D on CD8+ T cells have previously shown
contradicting results [10, 11]. In vivo, NKG2D engagement using
models systems with transgenic expression of its ligands enhances
both effector and memory CD8+ T-cell responses [12]. However,
hyperstimulation of costimulatory molecules may lead to super-
physiological responses or conversely, cause anergy [13, 14]. The
impact of NKG2D on T-cell priming is therefore best studied using
NKG2D-deficient cells. However, NKG2D plays a role in develop-
ment of NK and B cells [15] and Krk1−/− mice have hyperrespon-
sive NK cells. Studies in which NKG2D is specifically eliminated in
CD8+ T cells are so far lacking. Currently, it is unknown whether,
under physiological conditions, NKG2D functions as a costimula-
tory factor for CD8+ T-cell priming in vivo, or whether it only
mediates direct effector responses to target cells expressing its
ligands [15].
Here, we questioned whether NKG2D plays a role in CD8+
T-cell priming following viral infection, using models in which
NKG2D is specifically eliminated in these cells. We show that
NKG2D is not required for CD8+ T-cell expansion following viral
infection and has a redundant role in mediating cytotoxicity. In
contrast, cytokine production as well as their capacity to lower
viral loads following infection was impaired in NKG2D-deficient
CD8+ T cells. Reduced cytokine production by Klrk1−/− CD8+
T cells could be overcome using an IL-15 superagonist. Thus,
under physiological conditions, NKG2D plays a nonredundant role
in priming antiviral effector CD8+ T cells for the production of
cytokines.
Results
NKG2D deficiency impairs antiviral CD8+ T-cell
responses
We questioned whether effector CD8+ T-cell responses are
affected by the absence of NKG2D. First, we analyzed NKG2D
expression on effector, memory precursor, and na¨ıve T cells.
Wild-type (WT) and Klrk1−/− mice were infected with mouse
cytomegalovirus (mCMV). On day 8 after infection, NKG2D
expression was analyzed on virus-specific (Kbm57+) effector cells
(CD127−) and memory precursor cells (CD127+) in comparison
with na¨ıve T cells (CD62L+CD44Dim/−) from uninfected controls.
NKG2D expression was very low on na¨ıve cells, but was strongly
induced on both effector and memory cells (Fig. 1A). Next, WT
and Klrk1−/− mice were infected with mCMV and antigen-specific
T-cell responses were analyzed 8 days later. NKG2D deficiency
resulted in a two- to threefold reduction of CD8+ T cells specific
for two immune-dominant viral epitopes (Kbm57 and Kbm139)
in spleen and lymph nodes (LNs) (Fig. 1B). In vitro restimulation
with viral peptides also showed a strong reduction in IFN-γ pro-
duction by Klrk1−/− CD8+ T cells compared to controls (Fig. 1C).
Thus, NKG2D deficiency impairs CD8+ T-cell responses against
mCMV infection.
NKG2D deficiency does not affect naı¨ve T-cell
development
NKG2D deficiency impacts the development of NK and B cells [15].
Differences in effector T-cell responses of Klrk1−/− mice may
therefore be the result of alterations in the na¨ıve T-cell pool. No
differences were observed in the frequencies of thymic subpopula-
tions, peripheral CD4+ and CD8+ T-cell populations, or in regula-
tory T cells of Klrk1−/− mice compared toWT controls. Also, na¨ıve,
central memory, and effector memory CD8+ T-cell subpopulations
were unaffected by deficiency for NKG2D (Fig. 2A).
The impact of NKG2D on T-cell development may only become
apparent in a competitive setting. Therefore, WT and Klrk1−/− BM
cells were mixed in a 1:1 ratio and injected in lethally irradiated
hosts to generate mixed BM chimeras (mBMCs). After reconstitu-
tion, no differences were observed in the ratio between WT and
Klrk1−/− cells, either in thymic subpopulations or in total CD8+
T cells (Fig. 2B). In addition, the composition of CD8+ T-cell sub-
populations was not different between WT and Klrk1−/− cells in
the spleen or LNs of mBMCs (Fig. 2C). To investigate whether
WT- or Klrk1−/−-deficient stroma impacts development of T cells,
WT and Klrk1−/− mice were lethally irradiated and reconsti-
tuted with WT BM. NKG2D deficiency of the nonhematopoietic
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Figure 1. NKG2D-deficient mice have a reduced
CD8+ T-cell response to CMV infection. (A) WT
mice were infected with mCMV. After 7 days,
NKG2D expression was determined on Naive
(CD62L+CD44−), Memory (Kbm57+CD127+), and
effector (Kbm57+CD127−) CD8+ T cells from spleen
by flow cytometry. Dashed line indicates back-
ground (NKG2D staining of Klrk1−/− cells). (B, C)
WT and Klrk1−/− mice were infected with mCMV.
After 7 days (B) absolute numbers of Kbm57+ and
Kbm139+ cells were determined in spleen and LN.
(C) IFN-γproduction of splenic T cells after restimu-
lation with indicated peptides in vitro. Data shows
means ± SEM. Panel A shows pooled data of two
experiments with four mice per experiment. Data
in B and C show one of three experiments with five
mice per experiment. *p < 0.05, **p < 0.005, ***p <
0.001 (Student’s t-test or ANOVA with Bonferroni’s
post-test). GMI, geometric mean intensity.
environment did not impact thymic subpopulations, nor the
amount of CD4+ and CD8+ T cells in the spleen (Fig. 2D). Finally,
we investigated the capacity of na¨ıve NKG2D-deficient CD8+
T cells to produce cytokines upon in vitro stimulation. Splenocytes
from mBMCs were stimulated with PMA/Ionomycin or agonistic
CD3 antibodies. No differences were observed in the number of
CD8+ T cells producing IFN-γ, nor in the average level of IFN-γ
expression per cell (Fig. 2E). Therefore, we conclude that NKG2D
deficiency does not impact development of na¨ıve T cells.
NKG2D deficiency does not affect CD8+ T-cell
phenotype or homing
NKG2D deficiency in NK cells affects expression of several
inhibitory and activating receptors [15]. We questioned whether
altered expression of these receptors on effector cells is responsi-
ble for impaired CD8+ responses to mCMV infection. CD45.2+ WT
or NKG2D-deficient Klrk1/ OT1 T cells [16] were transferred to
WT (CD45.1+) recipients, which were subsequently infected with
mCMV expressing the SIINFEKL epitope of ovalbumin (mCMV-
SIINFEKL [17]). On day 7 after infection, donor cells were ana-
lyzed in spleen. However, no differences were observed between
WT and NKG2D-deficient CD8+ T cells for any of the investigated
markers (Fig. 3A).
Next, we assessed whether homing of CD8+ T cells is altered in
Klrk1−/− mice. WT (CD45.1) and Klrk1−/− (CD45.2) splenocytes
were mixed in a 1:1 ratio, labeled with CFSE, and transferred in
WT or Klrk1−/− hosts (CD45.2). One day later, donor cell numbers
were analyzed. No differences were observed in the ability of cells
to enter LNs, spleen, or circulation (Fig. 3B). To assess homing of
effector cells, total CD8+ T cells from WT and Klrk1−/− mice were
isolated 7 days after infection with mCMV, mixed in a 1:1 ratio,
CFSE labeled, and injected in coinfected hosts. One day later,
CD8+ T cells were analyzed. No differences were observed in the
ratio between total or antigen-specific effector WT and Klrk1−/−
CD8+ T cells in blood, LNs, or spleen (Fig. 3C and D). In summary,
NKG2D-deficiency does not affect cell surface marker expression
or homing of effector CD8+ T cells.
CD8+ T-cell specific NKG2D deficiency impairs IFN-γ
production
NKG2D mediates NK-cell education and its deficiency increases
their ability to fight mCMV infection [15]. Lymphocytic chori-
omeningitis virus (LCMV) is not controlled by NK cells, but by
CD8+ T cells [18]. We therefore analyzed effector CD8+ T-cell
expansion in WT and Klrk1−/− mice 8 days after LCMV infec-
tion. We did not observe differences in the percentage of antigen-
specific CD8+ T cells in spleen, LNs, and liver and found only a
minor reduction in absolute DbGp33+ cell numbers in spleen (Fig.
4A). This prompted us to investigate viral loads in Klrk1−/− mice
after mCMV infection. Indeed, we observed a persistent reduction
in viral titers both at early and late time points after infection
(Fig. 4B) that were lost when NK cells were depleted (Fig. 4C).
Thus, differences in NK-cell responses are responsible for changes
in antigenic load in Klrk1−/− mice after mCMV infection and may
impact CD8+ T-cell expansion.
To negate the effect of differential NK-cell functionality,
mBMCs were generated and infected with mCMV. Eight days after
infection, no differences were observed betweenWT and Klrk1−/−
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Figure 2. NKG2D does not affect CD8+ T-cell development (A) T cells of indicated organs were quantified by flow cytometry in 8-week-old WT and
Klrk1−/− mice. (B, C) mBMCs were generated using WT (CD45.1) and Klrk1−/− (CD45.1/2) BM mixed in a 1:1 ratio and injected in CD45.2 recipients.
Eight weeks after reconstitution (B) the fraction of WT donor cells was determined in (top) thymocytes and (bottom) the CD8+-cell populations of
the indicated organs. (C) The composition of CD8+ donor subpopulations was determined in spleen and LN. (D) WT or Klrk1−/− (CD45.2) recipients
were lethally irradiated and reconstituted with WT (CD45.1) BM. After 8 weeks, donor cell numbers were quantified in (left) thymus and (right)
spleen. (E) Splenocytes from mBMCs (WT: Klrk1−/−, 1:1) were stimulated in vitro with PMA/Ionomycin or αCD3 antibodies and IFN-γ production
of CD8+ T cells was assessed. Data show means ± SEM. Panels show a representative of two (B–D) or three (A, E) experiments using three to five
mice per experiment. GMI, geometric mean intensity; WBC, white blood cells; effector, (CD127−); CM, central memory (CD127+CD62L+CD44Bright);
EM, effector memory (CD127+CD62L−CD44+); naı¨ve, (CD127+CD62L+CD44Dim/−).
CD8+ T-cell expansion (Fig. 4D). NKG2D has been shown to pro-
mote cell division in T cells after stimulation in vitro [19]. To
test this in vivo, mBMCs were infected with mCMV and injected
every second day with BrdU. On day 8 after infection, BrdU incor-
poration was analyzed in effector CD8+ T cells. We observed
strong labeling of BrdU, indicative of rapid proliferation in all
effector cells. However, no differences in BrdU incorporation were
observed between WT and Klrk1−/− donor cells (Fig. 4E). Thus,
NKG2D deficiency does not impair effector CD8+ T-cell prolifera-
tion in response to mCMV infection.
Next, we assessed the functionality of Klrk1−/− CD8+ T cells
in mBMCs 8 days after mCMV infection. In vitro restimulation
with CD3ε antibodies or viral peptides showed no differences
in granzyme B expression (Fig. 4F). However, NKG2D-deficient
cells produced significantly less IFN-γ in response to restimulation
(Fig. 4G). To ensure a sufficient amount of WT help for
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Figure 3. NKG2D does not affect surface receptor expression or homing. (A) Recipient mice (CD45.1) received OT-1 or Klrk1/OT1 cells (both
CD45.2) and were infected with mCMV-SIINFEKL 1 day later. After 7 days, the phenotype of donor cells in spleen was determined by FACS. Shown
is geometric mean intensity (GMI) of which background signal is subtracted. (B) WT (CD45.1) and Klrk1−/− (CD45.2) splenocytes were mixed in a
1:1 ratio, labeled with CFSE and transferred in naive WT or Klrk1−/− hosts (CD45.2). Twenty four hours after transfer (day 1), donor cell numbers
were analyzed. Shown is the percentage of WT cells within the donor (CFSE+) CD8+ T-cell pool in blood, LN, and spleen before (day 0) and
after injection. (C, D) WT (CD45.1) and Klrk1−/− (CD45.2) mice were infected with mCMV. Seven days later, splenocytes were isolated, mixed in
a 1:1 ratio, labeled with CFSE and transferred in coinfected (CD45.2) WT or Klrk1−/− hosts. Twenty four hours after transfer, the percentage of
donor WT cells within (C) total CD8+ T cells and (D) CFSE+Kbm57+ effector cells was determined in the indicated organs and compared with
the percentage before injection (dashed line). Data shows means ± SEM and are representative of two experiments with three to five mice per
experiment.
expanding CD8+ T cells, mBMCs were generated using WT
and Klrk1−/− BM mixed in a 3:1 ratio. Also under these con-
ditions, total CD8+ T-cell expansion was unaffected by defi-
ciency for NKG2D, whereas IFN-γ production was reduced
upon mCMV infection (data not shown). Thus, IFN-γ produc-
tion, but not CD8+ T-cell expansion is reduced in absence of
NKG2D.
To investigate the impact of NKG2D-deficiency on CD8+
T cells in a second viral model, effector cell responses in mBMCs
were analyzed 8 days after LCMV infection. Again, we did
not observe changes in the ratio between WT and Klrk1−/−
donor cells of virus-specific CD8+ T cells compared to the
ratio before infection (Fig. 4H). In contrast, we observed a
large reduction in the ability of Klrk1−/− CD8+ T cells to pro-
duce IFN-γ, both after stimulation with CD3ε antibodies and
viral peptides (Fig. 4I). Thus, NKG2D promotes IFN-γ produc-
tion by antiviral CD8+ effector T cells also after infection with
LCMV.
In summary, NKG2D deficiency does not affect antiviral CD8+
T-cell expansion, but reduces IFN-γ expression in these cells.
T-cell specific NKG2D deficiency impairs cytokine
production, but not proliferation of CD8+ T cells
Next, we investigated whether the impaired ability of NKG2D-
deficient CD8+ T cells to produce cytokines was also observed
in T-cell specific NKG2D-deficient mice. Therefore, animals carry-
ing an allele of NKG2D flanked by LoxP sites [20] were crossed
with mice expressing cre recombinase behind the CD4+ promotor.
NKG2DFl/FlCD4Cre (NKG2DCKO) mice and NKG2DFl/Fl littermates
were infected with mCMV and the CD8+ T-cell response was ana-
lyzed 7 days later. Again, we did not observe any differences in
the relative and absolute numbers of virus-specific CD8+ T cells,
both for the Kbm57 and Kbm139 epitopes (Fig. 5A). In contrast, in
vitro restimulation with peptides or with CD3ε antibodies showed
that mice deficient for NKG2D produced significantly less IFN-
γ and TNF (Fig. 5B and C). Interestingly, after stimulation with
CD3 antibodies, but not with peptides, NKG2Dmice also showed a
reduced capacity to produce granzyme B (Fig. 5D). This suggests
that NKG2D deficiency may lead to reduced cytotoxic potential of
effector CD8+ T cells only after a strong antigenic stimulus.
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Figure 4. NKG2D deficiency impairs IFN-γ production but not proliferation of mCMV-specific CD8+ T cells. (A) WT and Klrk1−/− mice were infected
with LCMV. After 8 days, the percentage and absolute number of antigen-specific CD8+ T cells was determined in spleen, inguinal LNs, and liver.
(B) WT and Klrk1−/− mice were infected withmCMV and kinetics of viral load was followed over time in the liver. (C) Mice were treated with isotype
or NK-cell depleting antibodies. After 1 day, mice were infected with mCMV. Four days after infection, virus titers were determined in spleen. (D)
mBMCs (WT:Klrk1−/−, 1:1) were infected with mCMV and after 8 days, ratios between WT and Klrk1−/− cells were determined within Kbm57+ and
Kbm139+ effector cells. Dashed lines indicate CD8+ T-cell ratio in blood before infection. (E) mBMCs were infected with mCMV. On days 1, 3, 5, and
7 after infection, mice were injected with BrdU. On day 8 after infection, BrdU labeling of effector CD8+ T cells was determined in blood. Dashed
line indicates BrdU staining of CD8+ T cells from animals that were not injected with BrdU. (F and G) mBMCs were infected with mCMV. On day 8
after infection, the ratio within (F) granzyme B (GZMB) and (G) IFN-γ-producing cells after in vitro restimulation of splenic T cells with anti-CD3ε
antibodies or with m57 or m139 peptides. FACS plots are gated for CD8+ cells. (H–I) mBMCs (WT:Klrk1−/−, 1:1) were infected with LCMV and after 8
days, ratios between WT and Klrk1−/− cells were determined in spleen. Dashed lines indicate CD8+ T-cell ratio in blood before infection. (H) Ratio
within KbGp33+ effector cells. (I) Ratio within IFN-γ-producing cells after in vitro restimulation with anti-CD3ε antibodies or Gp33 peptides. FACS
plots are gated for CD8+ cells. Data shows mean ± SEM and are representative of two (A–C, E, H–I), or four (D, F) experiments with four to five
mice per experiment. *p < 0.05, **p < 0.005, ***p < 0.001 (Student’s t-test or ANOVA with Bonferroni’s post-test).
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Figure 5. T-cell specific NKG2D deficiency impairs cytokine production, but not proliferation of CD8+ T cells. NKG2DFl/FlCD4Cre (NKG2DCKO) mice
and NKG2DFl/Fl littermates were infected with mCMV and antiviral responses were analyzed after 7 days. (A) Relative and absolute Kbm57- and
Kbm139-specific CD8+ T-cell numbers. (B) IFN-γ, (C) TNF, and (D) granzyme B production was analyzed after in vitro restimulation of splenic
T cells, of NKG2DFl/Fl (closed spheres) or NKG2Dcko (open squares) mice with viral peptides or CD3ε antibodies. Data show means ± SEM and are
representative of two experiments with five mice per experiment. *p < 0.05, **p < 0.005 (Student’s t-test).
NKG2D deficiency impairs control of viral replication
by CD8+ T cells
To allow direct analysis of the antiviral capacity of NKG2D-
deficient CD8+ T cells, OT1 T cells were mixed with Klrk1/OT1
cells in a 1:1 ratio and transferred to WT recipients. Next,
recipients were infected with mCMV-SIINFEKL and donor cell
expansion was analyzed after 8 days. Donor cells had strongly
expanded and formed a significant fraction of the total CD8+
T-cell pool (Fig. 6A). However, similar to our observations using
mBMCs, NKG2D deficiency did not impact the ability of CD8+
T cells to expand in response to viral infection (Fig. 6B). IFN-γ pro-
duction, in contrast, was significantly impaired in Klrk1/OT1
cells (Fig. 6C). Thus, also in this transfer model, cytokine pro-
duction but not proliferation is impaired in CD8+ cells lacking
NKG2D.
To investigate the cytotoxic capacity of NKG2D-deficient CD8+
T cells, OT1 or Klrk1/OT1 cells were transferred to WT
(CD45.1) recipients and animals were infected with mCMV-
SIINFEKL. After 8 days, mice were injected with CD45.1+ spleno-
cytes pulsedwith SIINFEKL,m57, or influenza peptides. After 16 h,
killing of CD45.1+ cells was analyzed. The endogenous response
resulted in a reduction of m57-pulsed cells, though it was much
less potent than the SIINFEKL-directed response that is for more
than 90% dependent on donor cells (Fig. 6C). However, OT1 or
Klrk1/OT1 cells displayed no difference in their capacity to kill
SIINFEKL-pulsed cells (Fig. 6D). Thus, NKG2D deficiency does not
reduce cytotoxicity of CD8+ T cells.
To investigate the ability of NKG2D-deficient CD8+ T cells
to control viral replication, mice were transferred with OT1 or
Klrk1/OT1 cells. Next, animals were infected with mCMV-
SIINFEKL or mCMV and virus titers were followed over time
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Figure 6. NKG2D deficiency impairs control of
viral replication by CD8+ T cells. (A–C) OT1
(CD45.1/2) and Klrk1/OT1 (CD45.2) cells were
mixed in a 1:1 ratio and cells were transferred
toWT recipients (CD45.1). After 24 h, mice were
infected withPFU mCMV-SIINFEKL and 8 days
later CD8+ effector T-cell responses were ana-
lyzed. (A) Fraction of donor cells within the
total CD8+ T-cell pool (B) Ratio between OT1
and Klrk1/OT1 effector cells. (C) IFN-γ pro-
duction of CD8+ T cells from spleen restimu-
lated in vitro withm57 or Ova peptides. (D) OT1
or Klrk1/OT1 cells (both CD45.2) were trans-
ferred in naı¨ve WT (CD45.2) recipients. Twenty
four hours after transfer, mice were infected
with mCMV-SIINFEKL. Eight days after infec-
tion, splenocytes of naı¨ve WT mice (CD45.1)
were labeled with high, intermediate, or no lev-
els of CFSE and pulsed with SIINFEKL, m57,
or Flu peptides, respectively, and mixed in a
1:1:1 ratio. Cells were injected in infected ani-
mals and after 4 h, the ratio within donor
cells was determined in the spleens of infected
mice. Gates were set on CD45.1+CD45.2− cells.
(E) OT1 or Klrk1/OT1 cells were transferred
in naı¨ve WT recipients. Next, NK cells were
depleted with αNK1.1 antibodies. Twenty four
hours later, mice were infected with mCMV
or mCMV-SIINFEKL. Viral titers were deter-
mined in spleens. Data showmeans ± SEM and
are representative of two (D, E) or three (A–C)
experiments with three to five mice per exper-
iment. **p < 0.005, ***p < 0.001 (Student’s t-test,
ANOVA with Bonferroni’s post-test or Mann–
Whitney test).
in the spleen. On day 4 after infection, mice infected with
mCMV-SIINFEKL showed significantly lower virus titers in the
spleen compared to animals receiving mCMV (Fig. 6E). Strikingly,
Klrk1/OT1 cells failed to provide protection against mCMV-
SIINFEKL infection. Thus, NKG2D deficiency impairs the capacity
of CD8+ T cells to control viral replication when strong anti-
gens such as SIINFEKL are expressed by a pathogen. In sum-
mary, NKG2D deficiency does not affect the direct killing capacity
of CD8+ T cells, but reduces its ability to control viral replica-
tion, most likely as a result of their impaired ability to produce
cytokines.
NKG2D stimulation during priming promotes cytokine
production
To investigate directly whether NKG2D stimulation during prim-
ing regulates the ability of CD8+ T cells to produce cytokines
we used an in vitro model for effector cell differentiation [21].
Previously, we generated 3T3 cells overexpressing Rae1δ, Rae1ε,
Mult1, and H60 (Fig. 7A and [22, 23]), the NKG2D ligands present
in C57BL/6 mice. Purified OT-1 cells were stimulated with differ-
ent concentrations of SIINFEKL peptide, after which they were
placed on a monolayer of our 3T3 cell lines in the presence of
IL-2. After 2 days, cytokine production was assessed upon peptide
restimulation. Rae1δ, Rae1ε, and H60, but not Mult-1 promoted
IFN-γ and TNF production in OT-1 T cells after suboptimal TCR
stimulation (Fig. 7B–D). This effect was mediated through tran-
scriptional regulation, since IFN-γ mRNA levels closely correlated
with protein expression (Fig. 7C and E). Finally, we questioned
whether CD8+ T cells are primed through Dap10 or Dap12. T cells
of WT, Dap10−/−, or Dap12−/− mice were stimulated in vitro with
anti-CD3ε antibodies, after which they were cultured for 2 days
on 3T3 or 3T3-Rae1δ cells in the presence of IL-2. Peptide restim-
ulation showed that Rae1δ promoted IFN-γ production in WT and
Dap12−/− cells, but failed to achieve this effect in Dap10−/− cells
(Fig. 7F).
Thus, Dap10-dependent NKG2D stimulation during priming
regulates the ability of effector CD8+ T cells to produce cytokines
through transcriptional control.
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Figure 7. NKG2D stimulation during priming
promotes cytokine production. (A) 3T3 cells or
3T3 cells overexpressing Rae1δ, Rae1ε, Mult-1,
and H60 were stained for surface expression
of Rae1δ, Rae1ε, Mult-1, and H60, respectively.
Shown are representative FACS plots. (B–E) OT-
1 T cells were purified and primed with dif-
ferent concentrations of SIINFEKL. Next, cells
were transferred to wells with a monolayer of
the indicated 3T3 cells and cultured with IL-2.
After 2 days, cytokine production was analyzed
by intracellular flow cytometry upon SIINFEKL
restimulation. (B) IFN-γ production at indicated
concentrations of peptide during priming. (C)
IFN-γ and (D) TNF production of cells stimu-
lated with 0.01 ng/mL SIINFEKL during prim-
ing. (E) IFN-γ mRNA levels of cells primed with
SIINFEKL and costimulated with indicated 3T3
cell lines. Values were normalized to β-actin. (F)
WT, Dap10−/−, and Dap12−/− splenocytes were
primed with anti-CD3ε antibodies. Next, cells
were transferred to wells with a monolayer of
3T3 or 3T3-Rae1δ cells and cultured 2 days with
IL-2. IFN-γ production was analyzed by intra-
cellular flow cytometry 4 h after PI restimula-
tion. Data show means ± SEM and are repre-
sentative of one (E), or two (A–D, F) experiments
with three mice per experiment. *p < 0.05, **p
< 0.005, ***p < 0.001 (Student’s t-test or ANOVA
with Bonferroni’s post-test).
IL-15 superagonist rescues the reduced ability of
Klrk1−/− CD8+ T cells to produce IFN-γ
We next investigated whether CD8+ T cells stimulate NKG2D
in cis, or whether other immune cell subsets are involved. In
vitro generated effector CD8+ T cells did not express NKG2D lig-
ands (Fig. 8A). Therefore, we measured NKG2D ligands on classi-
cal dendritic cells (cDCs), plasmacytoid dendritic cells (pDCs),
macrophages and B cells, which represent the main APC sub-
sets, in mice infected 40 h prior with mCMV or in unin-
fected controls. Noninfected mice did not express NKG2D lig-
ands on any of the investigated populations (Fig. 8B and C
and data not shown). However, infection resulted in upregula-
tion of H60 on a subset of cDCs. H60-positive cDCs expressed
lower levels of CD11c (Fig. 8D), which is associated with
an activated phenotype [24]. Thus, in vivo, NKG2D on CD8+
T cells is likely triggered in trans by H60 on cDCs during
priming.
NKG2D potentiates IL-15 signaling toward PI3 kinase to pro-
motememory CD8+ T-cell formation [16].We questionedwhether
enhanced IL-15 signaling during priming in vivo could overcome
the reduced capacity of NKG2D-deficient effector CD8+ T cells
to produce IFN-γ. WT and Klrk1−/− mice were infected with
mCMV. After 2 days, mice were injected with PBS or with a mix-
ture of IL-15 and IL-15Rα-Fc fusion protein, which forms an IL-
15 superagonist (IL-15SA) [25]. Eight days after infection, the
ability of CD8+ T cells to produce IFN-γ was analyzed. IL-15SA
did not increase the capacity of WT CD8+ T cells to produce
IFN-γ in response to peptide restimulation, indicating already
optimal IL-15 access. However, production of IFN-γ by Klrk1−/−
cells was restored to WT levels after administration of IL-15SA
(Fig. 8E).
Thus, IL-15 stimulation is able to overcome the reduced ability
of Klrk1−/− effector CD8+ T cells to produce IFN-γ.
Discussion
NKG2D was shown to be able to promote CD8+ T-cell prolifer-
ation, cytotoxicity, and cytokine proliferation in various experi-
mental settings [19, 26]. However, due to the broad impact of
NKG2D deficiency on key antiviral immune cell subsets [15], until
now it was unclear whether NKG2D is a costimulatory molecule
for CD8+ T cells in vivo, or only targets them to cells express-
ing NKG2D ligands. We show that during viral infection, NKG2D
is not required for CD8+ T-cell expansion. Also, NKG2D defi-
ciency had a minor impact on cytotoxic potential, which only
became apparent following strong stimuli. However, we demon-
strate that NKG2D has a nonredundant costimulatory role on
effector CD8+ T cells that potentiates their ability to produce
cytokines.
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Figure 8. IL-15 superagonist rescues deficient
IFN-γ production of Klrk1−/− cells. (A) OT-1
T cells were stimulated as described for Fig.
7B. NKG2D ligand expression was assessed
by flow cytometry. Shown are representa-
tive histograms. (B–D) Mice were injected
i.v. with PBS or mCMV. After 40 h NKG2D
ligand expression was assessed in splenic cDC
(MHC-II+CD11c+CD11b+F4/80−PDCA-1−), pDC
(MHC-II+/dimCD11c+/dimCD11b−F4/80−PDCA-
1+), and macrophages (CD11b+F4/80+MHC-
II+CD19−GR1−) by flow cytometry. (B) Shown
are representative FACS plots (C) quantifica-
tion of H60 expression on cDC’s. (D) CD11c
expression on total cDC’s of noninfected mice
and H60+ and H60− Cdc’s of infected mice.
(E) WT and Klrk1−/− mice were infected with
mCMV. After 48 h, mice were injected once
with PBS or IL-15 superagonist. Seven days
after infection IFN-γ production was analyzed
after in vitro restimulation of splenocytes with
m57 peptides. Data show means ± SEM and
are representative of two experiments with
five mice per experiment. *p < 0.05, **p < 0.005,
***p < 0.001 (Student’s t-test or ANOVA with
Bonferroni’s post-test).
The impact of a particular costimulatory signal depends both
on the regulation of ligands on APCs and on receptor expression
on T cells. For example, CD27 and CD28 are both constitutively
expressed on CD8+ T cells [27]. However, whereas CD28 lig-
ands are broadly expressed, the CD27 ligand CD70 is only tran-
siently induced on a restricted number of cells [27, 28]. Other
costimulatory receptors, such as OX40 are only induced several
days after infection [29]. CD28 is therefore important for the
activation and expansion of na¨ıve CD8+ T cells, whereas OX40
promotes survival of activated effector CD8+ T cells several days
after initial antigen encounter [29]. Differential regulation of
costimulatory ligands and their receptors appears to be a way
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in which the efficiency and magnitude of the effector response
is fine-tuned to the requirements of a specific infection [30, 31].
Our findings indicate that, in the case of viral infection, the cos-
timulatory role of NKG2D is mostly restricted to regulation of
cytokine production. Interestingly, infected mBMCs did not show
a difference in granzyme B production between WT- and NKG2D-
deficient cells after infection, whereas NKG2DCKO mice did. This
may reflect an unappreciated role for NKG2D in CD4+ helper T-cell
function.
The discrepancy of our data with in vitro studies that show
a role for NKG2D in CD8+ T-cell expansion [11, 19, 26] is
possibly the result of differences in intensity of NKG2D stimu-
lation. In CD8+ T cells, NKG2D is linked to DAP10 and signals
to PI3 kinase (PI3K) [8]. PI3K is a potent signaling nexus that is
able to promote proliferation, cytotoxicity, and cytokine produc-
tion via various downstream signaling cascades [32]. The signal
intensity upstream of PI3K controls which downstream pathways
are activated. Low-intensity PI3K activation drives phosphoryla-
tion of Akt at Thr308, which is sufficient to induce cytokine pro-
duction [33]. High-intensity PI3K stimulation results in activation
of the mTOR signaling cascade, phosphorylating a second site
on Akt (Ser473) that enhances proliferation and induces expres-
sion of cytotoxic molecules [2, 34]. Our findings suggest that
CD8+ T cells encounter sufficient NKG2D ligands during prim-
ing to promote cytokine production, yet not enough to also drive
proliferation in vivo. Since IL-15 is a potent inducer of PI3K-
mediated effector cell functions [2], this might explain why IL-15
superagonists were able to overcome the effects of NKG2D defi-
ciency. In addition, cytokine production depends more on PI3K
signaling than cytotoxicity. In NK cells, loss of the PI3K subunit
p110δ prevented cytokine production, whereas cytotoxicity was
preserved [35].
Our findings do not downplay the important role of NKG2D
in control of viral infection. CMV expresses several immuno-
evasins, such as m152, which actively prevent surface expres-
sion of NKG2D ligands [36]. Infection with m152-deficient viruses
therefore results in reduced viral titers, partially because of an
enhanced T-cell response [37]. Indeed, NKG2D-deficient CD8+
T cells did have a reduced capacity to produce cytokines and had
impaired capacity to control viral replication, both after mCMV
and LCMV infection. Importantly, NKG2D-deficient effector CD8+
T cells were hyporesponsive to TCR engagement compared to WT
cells, even in the absence of overt NKG2D ligation. Thus, NKG2D
mediates both priming and direct target engagement of CD8+
T cells.
Our findings should be viewed within the limitations of our
study, such as the restricted number of antigen-specific responses
investigated. As shown in Fig. 7B, the effect of NKG2D-priming
is optimal within a window of T-cell stimulation strength. Fig-
ure 5D shows that NKG2D may have a similar impact on regu-
lation of cytotoxicity. We believe that our experiments show the
role of NKG2D on CD8+ T-cell priming in the most physiologi-
cal models to date. However, we should not disregard the dis-
crepancy between the costimulatory potential of NKG2D shown
by others [9, 10] and the actual role that we observe in vivo,
which may depend on the antigens studied. It will be interesting
to see whether NKG2D has a more potent role in CD8+ T-cell
priming against other epitopes, most notably those of a tumor
origin.
In summary, we show that during viral infection, the
role of NKG2D extends beyond the direct killing of ligand-
expressing target cells and actively contributes to priming of
effector CD8+ T cells. Our findings have important implica-
tions for vaccine strategies against viruses and tumors that aim
to exploit NKG2D signaling in CD8+ T cells to enhance their
effectiveness.
Materials and methods
Mice
Mice were age- and sex-matched within experiments and han-
dled according institutional and national guidelines. All ani-
mal experiments were performed after approval of our Insti-
tute’s Animal Ethics Committee. C57BL/6 (B6), OT-1, B6 CD45.1,
and CD4Cre mice were purchased from The Jackson Labo-
ratory. Dap10−/− and Dap12−/− mice were provided by M.
Colonna. Klrk1−/−, Klrk1Fl/Fl, and Klrk1/ mice were generated
as described previously [15, 20]. All lines were kept as breeding
colonies in our local animal facility under specific pathogen-free
conditions.
Surface and intracellular staining, Abs, and tetramers
Cell surface mAbs were purchased from eBioscience and BD Bio-
sciences, except for Rae1ε (R&D systems). Antibodies against
Rae1δ, Mult1, and H60 were made in-house [22, 23]. MHC class
I tetramers were a kind gift of Dr. Anja ten Brinke (Sanquin
Research). CFSE (Molecular Probes) and BrdU (BD Biosciences)
labeling and staining were performed according to manufactur-
ers’ protocols. For BrdU labeling, mice were injected i.p. every
second day with BrdU (0.8 mg). Intracellular staining was per-
formed using the BD Fix/Perm kit (cytokines) or the BrdU flow kit
(BrdU). Flow cytometry was measured on a FACScan, FACSCal-
ibur, FACSVerse, or FACSAria (BD Biosciences) and analyzed with
FlowJo software (Tree Star).
Viral infections and in vivo experiments
The BAC-derived murine CMV strain MW97.01 is biologically
equivalent to the mCMV Smith strain (VR-1399; ATCC) and is
referred to as mCMV [38]. mCMV strains were propagated on
MEF. NK-cell depletion was accomplished by i.p. injection of anti-
NK1.1 Abs (clone PK136; made in-house). Viral titers were deter-
mined on MEF by standard plaque assay. LCMV (Armstrong)
was propagated on BMK cells according to standard protocol.
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For in vivo IL-15 stimulation, mice were injected 48 h after
infection with IL-15/IL-15-Ra-Fc (0.2 mg/0.93 mg; R&D Systems)
as described [25]. BM recipients were lethally irradiated (9 Gy).
Recipient mice received 107 donor BM cells i.v. mBMCs received
WT and Klrk1−/− BM mixed in a 1:1 ratio. Experiments were
performed at least 8 weeks after transfer. OT1 or Klrk1/OT1
T cells were transferred i.v. using 10 000 cells per recipient.
For homing experiments, splenocytes were isolated from na¨ıve
mice or mice infected 7 days prior with mCMV. Donor cells
were mixed in a 1:1 ratio and labeled with CFSE. Cells were
injected i.v. in na¨ıve or coinfected mice. After 24 h, cell ratios
were determined in recipients. For in vivo killing experiments,
na¨ıve CD45.1 splenocytes were labeled with high (10 μg/mL),
intermediate (1 μg/mL), or no CFSE and pulsed with peptides (1
μg/mL). Populations were mixed in 1:1:1 ratios and injected in
CD45.2 recipients. Ratio between donor cells was determined after
16 h.
In vitro stimulations
For in vitro generation of effector cells, CD8+ T cells were puri-
fied from spleens by positive selection using the MACS cell sep-
aration system (Myltenyi), CFSE labeled, and cultured for 27 h
with SIINFEKL peptide (Genscript) or agonistic anti-CD3ε (145-
2C11) and anti-CD28 (37.51, eBioscience) antibodies in RPMI-
1640 medium (PAN-Biotech), supplemented with 10% FCS (PAN-
Biotech) and 2-ME (Sigma-Aldrich). Next, cells were washed and
cultured for 2 days with 100 ng/mL IL-2. 3T3 and NKG2D-L
3T3 cells were generated previously [22, 23]. In costimulation
assays, cells were cultured for 2 h in presence of Mytomycin
C (10 μg/mL) to block proliferation. Next, cells were washed
and plated out as a monolayer 24 h before transfer of activated
CD8+ T cells. For cytokine staining, cells were first restimu-
lated 4 h in vitro with 10 ng/mL peptides (Gp33-KAVYNFATC;
m57-SCLEFWQRV; m139-TVYGFCLL; Ova-SIINFEKL) or 5
mg/mL anti-CD3ε (145-2C11) in the presence of Brefeldin A
(eBioscience).
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